Trial Information

Summary: Evaluation of Prometrium ® capsules in subjects with secondary amenorrhea.

The primary objective of this study is to evaluate the efficacy and safety of 300 mg and 400 mg dose of micronized Progesterone capsules in women of reproductive age with secondary amenorrhea.

Several Study Inclusion Criteria Include:

• Women, 18-45 years old, with secondary amenorrhea of at least 90 days duration

Several Study Exclusion Criteria Include:

• Primary Amenorrhea
• Known sensitivity or contraindications to estrogen

Patients will be compensated for their participation

For more information

If you would like to learn more about participating in this study, please send an e-mail message using the form below.